For investors eyeing opportunities in the healthcare sector, Illumina, Inc. (NASDAQ: ILMN) presents a complex yet intriguing proposition. As a leader in the diagnostics and research industry, Illumina specializes in..
Illumina, Inc. (NASDAQ: ILMN) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. Based in the United States, this genomic powerhouse is renowned..
Illumina, Inc. (NASDAQ: ILMN), a prominent player in the healthcare sector specializing in diagnostics and research, is at a pivotal point as it navigates market fluctuations and investor expectations. With..
Illumina, Inc. (ILMN) stands as a pivotal entity in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $15.96 billion, Illumina is a trailblazer..
Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector, is renowned for its cutting-edge genomic and genetic sequencing solutions. Headquartered in San Diego, California, Illumina plays a pivotal role..
Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector specializing in diagnostics and research, stands at a critical juncture. With a market capitalization of $14.32 billion, the company operates..
Illumina, Inc. (NASDAQ: ILMN), a cornerstone in the healthcare sector, operates within the diagnostics and research industry. With a market cap of $13.76 billion, Illumina is a key player in..
Illumina, Inc. (NASDAQ: ILMN), a leading player in the diagnostics and research sector, stands at a crucial juncture as investors weigh its growth potential against current market challenges. With a..
Illumina, Inc. (NASDAQ: ILMN) stands as a pivotal player in the diagnostics and research sector, captivating investors with its innovative genomic and sequencing solutions. Despite recent challenges reflected in its..
Illumina, Inc. (NASDAQ: ILMN), a titan in the diagnostics and research industry, commands a significant presence in the healthcare sector with its cutting-edge sequencing and array-based solutions. Headquartered in San..
Illumina, Inc. which can be found using ticker (ILMN) now have 22 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price..
Illumina, Inc. which can be found using ticker (ILMN) have now 22 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price..
Illumina, Inc. with ticker code (ILMN) now have 22 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target..
Illumina, Inc. which can be found using ticker (ILMN) now have 22 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high..
Illumina, Inc. with ticker code (ILMN) have now 22 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target..
Illumina, Inc. with ticker code (ILMN) have now 22 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $253.00 and..
Illumina, Inc. which can be found using ticker (ILMN) now have 21 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges..
Illumina, Inc. with ticker code (ILMN) have now 21 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The range between the high target..
Illumina, Inc. which can be found using ticker (ILMN) have now 21 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges..
Illumina, Inc. which can be found using ticker (ILMN) now have 21 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high..
